Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-740-4 | CAS number: 137658-79-8 CGL 1545
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Based on the physico-chemical characteristics of the test substance (high molecular weight > 500 g/mol, poor water solubility < 1 mg/L, log Pow > 4, large particle sizes of 446 µm, low vapor pressure < 25 kPa)
dermal, oral and respiratory absorption is considered to be low. Due to this assumption, distribution of the substance is not assessed and its bioaccumulation is considered to be negligible. In the unlikely case of uptake the substance is assumed to undergo conjugation with glucuronic acid and to be excreted after phase II metabolism via the bile based on the high lipophilicity and the large molecular weight of the substance.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Absorption
Generally, oral absorption is favored for molecular weights below 500 g/mol and log Pow values between -1 and 4. As the substance is characterized by a high lipophilicity (log Pow > 4), high molecular weight (> 500 g/mol) and poor water solubility (< 0.1 mg/Lat 20 °C, pH ≈ 6), an absorption after oral uptake may be limited by the inability of the substance to dissolve in the fluids of the gastrointestinal tract and hence make contact with the mucosal surface unlikely. However, the absorption will be enhanced if the substance undergoes micellular solubilization by bile salts.
As the substance comprises of particles by far exceeding the boarder of the aerodynamic diameter for inhalable particles of 100 µm in human (85 % > 100 µm; 92 % > 40 µm), respiratory absorption via inhalation cannot be assumed. Moreover, the substance has a very low volatility. In the unlikely case of inhalation, absorption is regarded as low, but may be enhanced by micellular solubilization.
Skin penetration can be assumed to be negligible because the molecule may be too large for dermal uptake. As the molecular mass is above 500 g/mol and the value for the log Pow is outside the range between
-1 and 4, a value of 10 % skin absorption can be assumed (i). Also, in an animal study no signs of toxicity after dermal application of the substance occurred.
Metabolism
Almost the entire ingested test item is expected to pass the intestines unchanged and to be excreted directly via feces. In the unlikely case of uptake, the substance is assumed to undergo conjugation with glucuronic acid. Glucoronic acid conjugates are most likely formed with the present phenolic - OH groups. It is considered rather unlikely, that water-soluble metabolites would be formed by oxidation along the side chain and sulfation on the phenolic -OH groups. The substance contains ether bonds which are generally stable with regard to pH-dependent hydrolysis at pH values present in the gastrointestinal tract.
Excretion
As mentioned above, the substance is expected to be excreted unchanged via the feces. In the unlikely case of absorption, excretion is expected to take place after phase II metabolism via the bile based on the high lipophilicity and the large molecular weight of the substance.
Overall, no bioaccumulation of the test substance is expected, and no distribution is assessed as substance uptake is considered to be low.
(i) European Chemicals Agency, ECHA guidance on information requirements and chemical safety assessment. Chapter R.7c: Endpoint specific guidance. DOI:10.2823/43472.Version 3.0. June 2017
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.